Loading clinical trials...
Loading clinical trials...
Short Telomeres in Familial and Sporadic Fibrotic Interstitial Lung Diseases in Israel
Conditions
Interventions
leukocyte telomere length (LTL) will be measured using the Telomere Restriction Fragment (TRF) Analysis method
Locations
2
Israel
Barzilai Medical Center
Ashkelon, Israel
Tel Aviv Medical Center
Tel Aviv, Israel
Start Date
February 1, 2026
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2028
Last Updated
February 25, 2026
NCT06329401
NCT06238622
NCT07299695
NCT07466420
NCT06241560
NCT07407543
Lead Sponsor
Barzilai Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions